Skip to main content
SpringerLink
Log in

Dual vs triple antiplatelet/anticoagulant therapy after PCI

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. RE-DUAL PCI; PIONEER AF-PCI; AUGUSTUS; ENTRUST-AF PCI

References

  • 1. Khan SU, et al. Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis. Annals of Internal Medicine : 17 Mar 2020. Available from: URL: http://dx.doi.org/10.7326/M19-3763

  • 2. Doherty JU. Combined Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Navigating Between Scylla and Charybdis. Annals of Internal Medicine : 19 Mar 2020. Available from: URL: http://dx.doi.org/10.7326/M20-0572

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dual vs triple antiplatelet/anticoagulant therapy after PCI. Reactions Weekly 1797, 5 (2020). https://doi.org/10.1007/s40278-020-76512-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-76512-9

Search

Navigation